See our tirzepatide units conversion chart
Starting a new medication like semaglutide often raises concerns about affordability and access
placebo in obese individuals without diabetes: a systematic review and meta analysis
503B Outsourcing Facilities Patients who need a compounded product for a documented medical reason have a safer alternative path: 503B-registered outsourcing facilities
You may be a good candidate for medical weight loss treatment through Klinic if you are an adult with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, high cholesterol, cardiovascular disease, or obstructive sleep apnea
Real Treatments with Real Results Lose weight up to 15-20% On average, people on semaglutide lose 15-20% of their weight in a year Video Testimonials Videos of our Happy Customers Hear directly from patients who have participated in InjectCos weight loss program